Downregulation of human type III collagen gene expression by antisense oligodeoxynucleotide

Tissue Engineering

Volumn 11, Issue 9-10, 2005, Pages 1429-1435

  Jia, Fengyan ^a   Shimomura, Takatoshi ^a   Niyibizi, Christopher ^b   Woo, Savio L Y ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ENGINEERING; HISTOLOGY; IMMUNOLOGY; NUCLEIC ACIDS; PROTEINS; RNA; SENSORY PERCEPTION;

ANTISENSE; FIBRILS; GENE EXPRESSION; HEALING TISSUES;

COLLAGEN;

ANTISENSE OLIGODEOXYNUCLEOTIDE; COLLAGEN TYPE 3; MESSENGER RNA;

BIOMECHANICS; CONFERENCE PAPER; FIBER; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEALING; HUMAN; IMMUNOHISTOCHEMISTRY; LIGAMENT INJURY; PATELLA TENDON; PRIORITY JOURNAL; TENDON INJURY;

BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COLLAGEN TYPE III; DOWN-REGULATION; FEASIBILITY STUDIES; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; OLIGONUCLEOTIDES, ANTISENSE; PATELLAR LIGAMENT; PROCOLLAGEN; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 27744464325     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.1429     Document Type: Conference Paper

References (31)

1. Burgeson, R.E., and Nimni, M.E. Collagen types: Molecular structure and tissue distribution. Clin. Orthop. Relat. Res. 282, 250, 1992.
2. Kadler, K.E., Holmes, D.F., Trotter, J.A., and Chapman, J.A. Collagen fibril formation. Biochem. J. 316, 1, 1996.
3. Frank, C., Woo, S.L-Y., Amiel, D., Harwood, F., Gomez, M., and Akeson, W. Medial collateral ligament healing: A multidisciplinary assessment in rabbits. Am. J. Sports Med. 11, 379, 1983.
4. Amiel, D., Frank, C.B., Harwood, F.L., Akeson, W.H., and Kleiner, J.B. Collagen alteration in medial collateral ligament healing in a rabbit model. Connect. Tissue Res. 16, 357, 1987.
5. Gomez, M.A., Woo, S.L-Y., Inoue, M., Amiel, D., Harwood, F.L., and Kitabayashi, L. Medical collateral ligament healing subsequent to different treatment regimens. J. Appl. Physiol. 66, 245, 1989.
6. Niyibizi, C., Kavalkovich, K., Yamaji, T., and Woo, S.L-Y. Type V collagen is increased during rabbit medial collateral lateral ligament healing. Knee Surg. Sports Traumatol. Arthrose. 8, 281, 2000.
7. Boykiw, R., Sciore, P., Reno, C., Marchuk, L., Frank, C.B., and Hart, D. A. Altered levels of extracellular matrix molecule mRNA in healing rabbit ligaments. Matrix Biol. 17, 371, 1998.
8. Inoue, M., Woo, S.L-Y., Gomez, M.A., Amiel, D., Ohland, K.J., and Kitabayashi, L.R. Effects of surgical treatment and immobilization on the healing of the medial collateral ligament: A long-term multidisciplinary study. Connect. Tissue Res. 25, 13, 1990.
9. Frank, C., McDonald, D., Bray, D., Bray, R., Rangayyan, R., Chimich, D., and Shrive, N. Collagen fibril diameters in the healing adult rabbit medial collateral ligament. Connect. Tissue Res. 27, 251, 1992.
10. Frank, C., McDonald, D., and Shrive, N. Collagen fibril diameters in the rabbit medial collateral ligament scar: A longer term assessment. Connect. Tissue Res. 36, 261, 1997.
11. Frank, C., Bray, R.C., Hart, D.A., Shrive, N.G., Loitz, B.J., Matyas, J.R., and Wilson, J.E. Soft tissue healing. In: Knee Surgery. Fu, F.H., Harner, C.D., and Vince, K.G., eds. Baltimore, MD: Williams & Wilkins, 1994, pp. 189-230.
12. Frank, C., McDonald, D., Wilson, J., Eyre, D., and Shrive, N. Rabbit medial collateral ligament scar weakness is associated with decreased collagen pyridinoline crosslink density. J. Orthop. Res. 13, 157, 1995.
13. Parry, D.A., Barnes, G.R., and Craig, A.S. A comparison of the size distribution of collagen fibrils in connective tissues as a function of age and a possible relation between fibril size distribution and mechanical properties. Proc. R. Soc. Lond. B Biol. Sci. 203, 305, 1978.
14. Doillon, C.J., Dunn, M.G., Bender, E., and Silver, F.H. Collagen fiber formation in repair tissue: Development of strength and toughness. Coll. Relat. Res. 5, 481, 1985.
15. Birk, D.E., and Mayne, R. Localization of collagen types I, III and V during tendon development: Changes in collagen types I and III are correlated with changes in fibril diameter. Eur. J. Cell Biol. 72, 352, 1997.
16. Notbohm, H., Mosler, S., Muller, P.K., and Brinckmann, J. In vitro formation and aggregation of heterotypic collagen I and III fibrils. Int. J. Biol. Macromol. 15, 299, 1993.
17. Lapiere, C.M., Nusgens, B., and Pierard, G.E. Interaction between collagen type I and type III in conditioning bundles organization. Connect. Tissue Res. 5, 21, 1977.
18. Romanic, A.M., Adachi, E., Kadler, K.E., Hojima, Y., and Prockop, D.J. Copolymerization of pNcollagen III and collagen I: pNcollagen III decreases the rate of incorporation of collagen I into fibrils, the amount of collagen I incorporated, and the diameter of the fibrils formed. J. Biol. Chem. 266, 12703, 1991.
19. Alama, A., Barbieri, F., Cagnoli, M., and Schettini, G. Antisense oligonucleotides as therapeutic agents. Pharmacol. Res. 36, 171, 1997.
20. Stein, C.A., and Cohen, J.S. Oligodeoxynucleotides as inhibitors of gene expression: A review. Cancer Res. 48, 2659, 1988.
21. Laptev, A.V., Lu, Z., Colige, A., and Prockop, D.J. Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides: The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA. Biochemistry 33, 11033, 1994.
22. Wang, Q., and Marini, J.C. Antisense oligodeoxynucleotides selectively suppress expression of the mutant α2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts: A molecular approach to therapeutics of dominant negative disorders. J. Clin. Invest. 97, 448, 1996.
23. Colige, A., Sokolov, B.P., Nugent, P., Baserga, R., and Prockop, D.J. Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells. Biochemistry 32, 7, 1993.
24. Nakamura, N., Horibe, S., Matsumoto, N., Tomita, T., Natsuume, T., Kaneda, Y., Shino, K., and Ochi, T. Transient introduction of a foreign gene into healing rat patellar ligament. J. Clin. Invest. 97, 226, 1996.
25. Nakamura, N., Hart, D.A., Boorman, R.S., Kaneda, Y., Shrive, N.G., Marchuk, L.L., Shino, K., Ochi, T., and Frank, C.B. Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo. J. Orthop. Res. 18, 517, 2000.
26. Shimomura, T., Jia, F., Niyibizi, C., and Woo, S.L-Y. Antisense oligonucleotides reduce synthesis of procollagen α1(V) chain in human patellar tendon fibroblasts: Potential application in healing ligaments and tendons. Connect. Tissue Res. 44, 167, 2003.
27. Chiang, M.Y., Chan, H., Zounes, M.A., Freier, S.M., Lima, W.F., and Bennett, C.F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266, 18162, 1991.
28. Li, S., and Huang, L. Funcational pleiomorphism of liposomal gene delivery vectors: Lipoplex and lipoplyplex. In: Janoff, A.S., ed. Liposomes: Rational Design. New York: Marcel Dekker, 1999, pp. 89-124.
29. Lo, I.K., Marchuk, L.L., Hart, D.A., and Frank, C.B. Comparison of mRNA levels for matrix molecules in normal and disrupted human anterior cruciate ligaments using reverse transcription-polymerase chain reaction. J. Orthop. Res. 16, 421, 1998.
30. Linsenmayer, T.F., Igoe, F., Gibney, E., Gordon, M.K., and Birk, D.E. Positive regulation of corneal type V collagen mRNA: Analysis by chicken-human heterokaryon formation. Exp. Cell Res. 228, 36, 1996.
31. Kitamura, Y., Tanigawa, T., Nanba, E., Ueno, E., Fukumoto, S., and Ichihara, K. Antisense oligonucleotide inhibits the expression of procollagen type III gene in mouse fibroblasts. Biochem. Biophys. Res. Commun. 215, 849, 1995.